Further studies on neomycin and experimental hypertension

Area of Science:

• Endocrinology
• Pharmacology
• Microbiology

Background:

• Glucocorticoids can induce hypertension.
• Gut bacteria are known to metabolize steroids.
• Neomycin has previously shown to attenuate certain types of glucocorticoid-induced hypertension.

Purpose of the Study:

• To investigate the effect of oral neomycin on blood pressure in rats with hypertension induced by various glucocorticoids.
• To explore the relationship between neomycin's effect and the specific glucocorticoid administered.

Main Methods:

• Oral administration of neomycin to rats.
• Induction of hypertension using different glucocorticoids (ACTH, corticosterone, prednisolone, dexamethasone, cortisol).
• Monitoring of blood pressure changes in response to neomycin and glucocorticoid treatments.

Main Results:

• Neomycin significantly attenuated hypertension induced by ACTH, corticosterone, and prednisolone.
• Neomycin did not affect blood pressure in rats treated with dexamethasone or cortisol.
• The observed effects did not correlate with the pressor or glucocorticoid activity of the steroids.

Conclusions:

• Neomycin's ability to attenuate glucocorticoid-induced hypertension is steroid-specific.
• The differential effect of neomycin suggests it is related to the enterohepatic handling and metabolism of the specific glucocorticoids.
• Gut bacterial metabolism likely plays a role in the varying responses to neomycin treatment.